Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal
Published . Updated .
Key takeaways
- The Journal of Health Care Compliance has published an analysis by McGuireWoods’ Francesca Ozinal and Timothy Fry of recent guidance from the Department of Health and Human Services (HHS) regarding...
- Exposed: HHS, XLV, XBI, EWQ, LLY
- Market reaction: HHS +1.2% on the day (still updating); XLV −2.1% on the day (still updating); UNH −5.0% on the day (still updating)
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
The Journal of Health Care Compliance has published an analysis by McGuireWoods’ Francesca Ozinal and Timothy Fry of recent guidance from the Department of Health and Human Services (HHS) regarding...
Directly affected
- HHS Harte Hanks
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- EWQ iShares MSCI France ETF-0.5% 6d
iShares MSCI France ETF holds stocks listed in France, which this story is about (“france”).
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- UNH UnitedHealth Group+6.0% 30d
UnitedHealth Group (hospital and medical service plans): health insurers' costs move with medical prices and policy. Linked by “medicare” (health insurers and care costs) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| HHS | +7.05% | +1.60% | base | +1.20% | after close | after close | after close |
| XLV | +3.66% | +3.71% | base | -2.13% | after close | after close | after close |
| XBI | +4.22% | +0.59% | base | -0.14% | after close | after close | after close |
| EWQ | +3.23% | +2.33% | base | -1.26% | after close | after close | after close |
| LLY | +3.43% | +3.72% | base | -2.21% | after close | after close | after close |
| JNJ | +3.98% | +3.63% | base | -2.03% | after close | after close | after close |
| PFE | +2.74% | +2.92% | base | -1.67% | after close | after close | after close |
| MRK | +6.65% | +4.90% | base | -3.46% | after close | after close | after close |
| UNH | +15.78% | +17.77% | base | -4.96% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal McGuireWoods
Source: McGuireWoods
How far Select Sector Spdr Tr (XLV) has moved since 19 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Ishares (EWQ) | that day | -1.26% | still updating |
| Ishares (EWQ) | three days earlier | +2.33% | final price |
| Ishares (EWQ) | five days earlier | +3.23% | final price |
| HHS | that day | +1.20% | still updating |
| HHS | three days earlier | +1.60% | final price |
| HHS | five days earlier | +7.05% | final price |
| Johnson & Johnson (JNJ) | that day | -2.03% | still updating |
| Johnson & Johnson (JNJ) | three days earlier | +3.63% | final price |
| Johnson & Johnson (JNJ) | five days earlier | +3.98% | final price |
| Eli Lilly (LLY) | that day | -2.21% | still updating |
| Eli Lilly (LLY) | three days earlier | +3.72% | final price |
| Eli Lilly (LLY) | five days earlier | +3.43% | final price |
| MRK | that day | -3.46% | still updating |
| MRK | three days earlier | +4.90% | final price |
| MRK | five days earlier | +6.65% | final price |
| Pfizer (PFE) | that day | -1.67% | still updating |
| Pfizer (PFE) | three days earlier | +2.92% | final price |
| Pfizer (PFE) | five days earlier | +2.74% | final price |
| Unitedhealth Group (UNH) | that day | -4.96% | still updating |
| Unitedhealth Group (UNH) | three days earlier | +17.77% | final price |
| Unitedhealth Group (UNH) | five days earlier | +15.78% | final price |
| XBI | that day | -0.14% | still updating |
| XBI | three days earlier | +0.59% | final price |
| XBI | five days earlier | +4.22% | final price |
| Select Sector Spdr Tr (XLV) | that day | -2.13% | still updating |
| Select Sector Spdr Tr (XLV) | three days earlier | +3.71% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | +3.66% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 16 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 30 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 76 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 43 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 50 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 76 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 90 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Unitedhealth Group (UNH), worth $1,001 - $15,000 on 24 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Unitedhealth Group (UNH) (jointly held), worth $15,001 - $50,000 on 23 Sep 2026. That is 57 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Kevin Hern sold Unitedhealth Group (UNH) (jointly held), worth $15,001 - $50,000 on 10 Sep 2026. That is 70 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies mentioned with this story
- XLV Select Sector Spdr Tr
In “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds health insurers and care providers. Linked by “medicare” (health insurers and care costs) in this story
- IHF Ishares U.S. Healthcare Providers Etf
In “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal,” Ishares U.S. Healthcare Providers Etf (IHF) is linked, with no stored direction, medium confidence. Reason on file: iShares U.S. Healthcare Providers ETF: it holds health insurers and care providers. Linked by “medicare” (health insurers and care costs) in this story
- EWQ Ishares
In “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal,” Ishares (EWQ) is linked, with no stored direction, medium confidence. Reason on file: iShares MSCI France ETF holds stocks listed in France, which this story is about (“france”)
- LLY Eli Lilly
In “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- UNH Unitedhealth Group
Unitedhealth Group (UNH) is linked, with no stored direction, medium confidence in the 19 Nov 2026 story “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal.” Reason on file: UnitedHealth Group (hospital and medical service plans): health insurers' costs move with medical prices and policy. Linked by “medicare” (health insurers and care costs) in this story
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 19 Nov 2026 story “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal.” Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- ELV Elevance Health
In “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal,” Elevance Health (ELV) is linked, with no stored direction, medium confidence. Reason on file: Elevance Health (hospital and medical service plans): health insurers' costs move with medical prices and policy. Linked by “medicare” (health insurers and care costs) in this story
- PFE Pfizer
Pfizer (PFE) is linked, with no stored direction, medium confidence in the 19 Nov 2026 story “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal.” Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
Select Sector Spdr Tr (XLV)
On 19 Nov 2026, “Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal” is the story that connects Select Sector Spdr Tr (XLV) to this story.
For Select Sector Spdr Tr (XLV), the reason on file says Health Care Select Sector SPDR: it holds health insurers and care providers. Linked by “medicare” (health insurers and care costs) in this story
A second company, Ishares U.S. Healthcare Providers Etf (IHF), is listed for a different reason: iShares U.S. Healthcare Providers ETF: it holds health insurers and care providers. Linked by “medicare” (health insurers and care costs) in this story
Dates in the story, and the Select Sector Spdr Tr (XLV) price range
EWQ traded between 40.92 and 42.05 across 6 sessions. The latest close on file is 41.61. IHF traded between 55.16 and 60.46 across 12 sessions. The latest close on file is 59.98.
What the saved facts support for Select Sector Spdr Tr (XLV)
46 out of 100Price not final
“Francesca Ozinal, Timothy Fry Unpack OIG Medicare Advantage Guidance in Healthcare Journal” scores 46 out of 100. The score uses 1 source, and 8 linked companies. The price is not final yet.